Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wolf-Hirschhorn syndrome candidate 1-like 2, pseudogene (WHSC1L2P)
- Target
- WHSC1L2P
- Molecular classification
- Other (pseudogene)
01
Overview
WHSC1L2P (Wolf-Hirschhorn syndrome candidate 1-like 2, pseudogene) is a human pseudogene related by sequence homology to the functional histone methyltransferases WHSC1 (NSD2/MMSET) and possibly WHSC1L1 (NSD3), both of which are implicated in epigenetic regulation through histone methylation, cell differentiation, and oncogenesis[2][4]. However, WHSC1L2P itself lacks protein-coding capacity and functional characterization; there is no evidence it encodes an active histone methyltransferase or participates in signaling pathways or cellular processes. Accordingly, it is not considered a therapeutic target, receptor, enzyme, transporter, or biomarker, and there are neither known drugs nor clinical applications associated with it[2]. Its annotation and aliases reflect its sequence similarity and historical naming conventions, but scientific literature does not attribute any biological activities, disease roles, or therapeutic significance to this pseudogene.
- Other names
- NSD4PHsT36289WHSC1L1PWolf-Hirschhorn syndrome candidate 1-like 1 pseudogene
Beyond the preview
Go deeper on Wolf-Hirschhorn syndrome candidate 1-like 2, pseudogene (WHSC1L2P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wolf-Hirschhorn syndrome candidate 1-like 2, pseudogene (WHSC1L2P).